Showing results (241-250 of 2,609) with videos related to
Sort By:
Pageof 261
Oncology Research|January 1, 1997
A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune miceL Z Iakoubov, V P TorchilinOncology Research|July 14, 2015
shRNA Depletion of cIAP1 Sensitizes Human Ovarian Cancer Cells to Anticancer Agent-Induced ApoptosisHong Jin, You-Yuan Dong, Hong Zhang, et al.Oncology Research|May 21, 2020
Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In VivoLeonard Lothstein, Judith Soberman, Deanna Parke, et al.Oncology Research|July 27, 2016
Knockdown of HVEM, a Lymphocyte Regulator Gene, in Ovarian Cancer Cells Increases Sensitivity to Activated T CellsTing Zhang, Lei Ye, Lingfei Han, et al.Oncology Research|April 11, 2020
miR-202 Suppresses Hepatocellular Carcinoma Progression via Downregulating BCL2 ExpressionDonghai Zhuang, Li Liang, Hongzhan Zhang, et al.Oncology Research|April 26, 2020
The AKT/GSK3-Mediated Slug Expression Contributes to Oxaliplatin Resistance in Colorectal Cancer via Upregulation of ERCC1Wei Wei, Xiao-Dong Ma, Guan-Min Jiang, et al.Oncology Research|June 19, 2003
Novel sigma binding site ligands as inhibitors of cell proliferation in breast cancerFederica Barbieri, Anna Sparatore, Angela Alama, et al.Oncology Research|January 1, 1992
In vivo sensitization of human lung carcinoma to bleomycin by the cysteine proteinase inhibitor E-64J P Jani, J S Mistry, G Morris, et al.Oncology Research|January 1, 1992
Apoptosis of rat thymocytes triggered by prednisolone, camptothecin, or teniposide is selective to G0 cells and is prevented by inhibitors of proteasesS Bruno, P Lassota, W Giaretti, et al.Oncology Research|February 24, 2001
Structure-activity studies of novobiocin analogs as modulators of the cytotoxicity of etoposide (VP-16)G Rappa, K Shyam, A Lorico, et al.Pageof 261